Warning letter
Eniva USA, Inc.: warning letter of Sep 10, 2025
FDA warning letter 706565 · Human Foods Program
Key facts
| Reference number | 706565 |
|---|---|
| Company | Eniva USA, Inc. |
| Subject | CGMP/Dietary Supplement/Adulterated/Misbranded |
| Issue date | Sep 10, 2025 |
| Posted date | Feb 3, 2026 |
| Issuing office | Human Foods Program |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.140(b)(3), 111, 111.70(e), 114.83 |
| Inspection city | Plymouth |
| Inspection ZIP | 55441 |
| Inspection start date | Nov 19, 2024 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: